| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 435.72M | 360.66M | 325.06M | 321.23M | 445.47M | 405.11M |
| Gross Profit | 249.08M | 201.56M | 182.94M | 177.83M | 217.83M | 189.99M |
| EBITDA | 118.16M | 94.05M | 88.64M | 82.63M | 98.59M | 72.06M |
| Net Income | 52.37M | 39.81M | 38.46M | 11.64M | 52.06M | 38.19M |
Balance Sheet | ||||||
| Total Assets | 742.85M | 493.35M | 569.36M | 572.11M | 601.56M | 496.05M |
| Cash, Cash Equivalents and Short-Term Investments | 201.19M | 46.16M | 117.89M | 106.40M | 128.32M | 41.77M |
| Total Debt | 307.17M | 261.27M | 377.99M | 420.45M | 430.48M | 333.46M |
| Total Liabilities | 384.69M | 302.97M | 417.35M | 458.73M | 467.84M | 378.56M |
| Stockholders Equity | 343.95M | 187.98M | 150.98M | 111.64M | 131.40M | 113.44M |
Cash Flow | ||||||
| Free Cash Flow | 38.97M | 62.44M | 61.17M | 22.59M | 62.06M | 37.54M |
| Operating Cash Flow | 50.26M | 67.06M | 66.88M | 30.27M | 68.22M | 43.68M |
| Investing Cash Flow | -29.83M | -10.51M | -5.91M | -18.79M | -58.84M | -64.82M |
| Financing Cash Flow | 147.49M | -128.15M | -49.51M | -43.30M | 57.07M | -29.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $2.97B | 28.14 | 4.71% | 0.33% | 51.49% | 21.43% | |
68 Neutral | $1.92B | 35.50 | 22.54% | 0.29% | 6.71% | 8.16% | |
68 Neutral | $1.30B | 11.77 | 7.72% | 6.24% | 3.01% | -7.14% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
51 Neutral | $131.77M | ― | -254.99% | ― | -20.13% | -88.66% | |
45 Neutral | $4.88M | >-0.01 | -133.50% | ― | -34.81% | 99.30% | |
31 Underperform | $5.74M | -0.60 | -68.63% | ― | -88.85% | 68.28% |
On December 13, 2024, Turning Point Brands, Inc. entered into an at-the-market sales agreement with B. Riley Securities, Inc. and Barclays Capital Inc. to issue and sell shares of its common stock. The company has amended its prospectus supplement to increase the aggregate dollar amount of common stock available for sale by $200 million, following previous sales totaling nearly $100 million. This move could potentially enhance the company’s financial flexibility and market positioning.